Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

1.

[Stem cell therapy for dementia].

Honmou O.

Brain Nerve. 2015 Jan;67(1):93-8. doi: 10.11477/mf.1416200091. Japanese.

PMID:
25585438
2.

Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats.

Suzuki S, Kawamata J, Iwahara N, Matsumura A, Hisahara S, Matsushita T, Sasaki M, Honmou O, Shimohama S.

Neurosci Lett. 2015 Jan 1;584:276-81. doi: 10.1016/j.neulet.2014.10.039. Epub 2014 Nov 1.

PMID:
25449872
3.

[Cell therapy for stroke].

Honmou O.

Rinsho Shinkeigaku. 2013;53(11):1175-6. Japanese.

PMID:
24291919
4.

Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model.

Suzuki J, Sasaki M, Harada K, Bando M, Kataoka Y, Onodera R, Mikami T, Wanibuchi M, Mikuni N, Kocsis JD, Honmou O.

Brain Res. 2013 Feb 25;1497:15-22. doi: 10.1016/j.brainres.2012.12.028. Epub 2012 Dec 27.

PMID:
23274536
5.

Bone marrow stem cells in experimental stroke.

Kocsis JD, Honmou O.

Prog Brain Res. 2012;201:79-98. doi: 10.1016/B978-0-444-59544-7.00005-6. Review.

PMID:
23186711
6.

Therapeutic effects of human mesenchymal and hematopoietic stem cells on rotenone-treated parkinsonian mice.

Inden M, Takata K, Nishimura K, Kitamura Y, Ashihara E, Yoshimoto K, Ariga H, Honmou O, Shimohama S.

J Neurosci Res. 2013 Jan;91(1):62-72. doi: 10.1002/jnr.23128. Epub 2012 Oct 17.

PMID:
23073839
7.

Mesenchymal stem cells: therapeutic outlook for stroke.

Honmou O, Onodera R, Sasaki M, Waxman SG, Kocsis JD.

Trends Mol Med. 2012 May;18(5):292-7. doi: 10.1016/j.molmed.2012.02.003. Epub 2012 Mar 27. Review.

PMID:
22459358
8.

[Bone marrow stem cell therapy for stroke].

Sasaki Y, Honmou O.

Nihon Rinsho. 2011 Dec;69(12):2203-8. Japanese.

PMID:
22242320
9.

Expression of aquaporin-4 augments cytotoxic brain edema after traumatic brain injury during acute ethanol exposure.

Katada R, Nishitani Y, Honmou O, Mizuo K, Okazaki S, Tateda K, Watanabe S, Matsumoto H.

Am J Pathol. 2012 Jan;180(1):17-23. doi: 10.1016/j.ajpath.2011.09.011. Epub 2011 Nov 1.

10.

Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells.

Sasaki M, Honmou O, Radtke C, Kocsis JD.

PLoS One. 2011;6(10):e26577. doi: 10.1371/journal.pone.0026577. Epub 2011 Oct 24.

11.

Identification of chemoattractive factors involved in the migration of bone marrow-derived mesenchymal stem cells to brain lesions caused by prions.

Song CH, Honmou O, Furuoka H, Horiuchi M.

J Virol. 2011 Nov;85(21):11069-78. doi: 10.1128/JVI.05318-11. Epub 2011 Aug 3.

12.

Mesenchymal stem cells transmigrate across brain microvascular endothelial cell monolayers through transiently formed inter-endothelial gaps.

Matsushita T, Kibayashi T, Katayama T, Yamashita Y, Suzuki S, Kawamata J, Honmou O, Minami M, Shimohama S.

Neurosci Lett. 2011 Sep 8;502(1):41-5. doi: 10.1016/j.neulet.2011.07.021. Epub 2011 Jul 20.

PMID:
21798315
13.

Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.

Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, Waxman SG, Kocsis JD.

Brain. 2011 Jun;134(Pt 6):1790-807. doi: 10.1093/brain/awr063. Epub 2011 Apr 14.

14.

Remyelination after olfactory ensheathing cell transplantation into diverse demyelinating environments.

Sasaki M, Lankford KL, Radtke C, Honmou O, Kocsis JD.

Exp Neurol. 2011 May;229(1):88-98. doi: 10.1016/j.expneurol.2011.01.010. Epub 2011 Jan 28. Review.

PMID:
21281634
15.

[Stem cell therapy for cerebral ischemia].

Honmou O, Houkin K.

No Shinkei Geka. 2010 Jun;38(6):515-20. Review. Japanese. No abstract available.

PMID:
20543224
16.

Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome.

Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, Hamada H, Kocsis JD.

Brain Res. 2010 Jul 9;1343:226-35. doi: 10.1016/j.brainres.2010.05.011. Epub 2010 May 12.

PMID:
20470759
17.

Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia.

Komatsu K, Honmou O, Suzuki J, Houkin K, Hamada H, Kocsis JD.

Brain Res. 2010 Jun 2;1334:84-92. doi: 10.1016/j.brainres.2010.04.006. Epub 2010 Apr 9.

PMID:
20382136
18.

BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury.

Sasaki M, Radtke C, Tan AM, Zhao P, Hamada H, Houkin K, Honmou O, Kocsis JD.

J Neurosci. 2009 Nov 25;29(47):14932-41. doi: 10.1523/JNEUROSCI.2769-09.2009.

19.

Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia.

Zheng W, Honmou O, Miyata K, Harada K, Suzuki J, Liu H, Houkin K, Hamada H, Kocsis JD.

Brain Res. 2010 Jan 15;1310:8-16. doi: 10.1016/j.brainres.2009.11.012. Epub 2009 Nov 12.

PMID:
19913518
20.

Prior ethanol injection promotes brain edema after traumatic brain injury.

Katada R, Nishitani Y, Honmou O, Okazaki S, Houkin K, Matsumoto H.

J Neurotrauma. 2009 Nov;26(11):2015-25. doi: 10.1089/neu.2008.0552.

PMID:
19558208
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk